# New Drug May Combat Muscle Loss from Popular Weight Loss Injections
Patients taking semaglutide and tirzepatide for weight loss face an unexpected problem. About one-third of the weight these medications shed comes from muscle tissue, not just fat. Researchers now report that a new drug could protect lean muscle during treatment.
Semaglutide (marketed as Ozempic and Wegovy) and tirzepatide (Zepbound and Mounjaro) have transformed obesity treatment. Both drugs suppress appetite and improve blood sugar control, leading to rapid weight loss. But this comes with a catch. As patients lose weight quickly, their bodies break down muscle along with fat, a phenomenon colloquially called "Ozempic butt."
This muscle loss has real consequences. Lean muscle supports metabolism, bone strength, and functional fitness. Losing it can leave people feeling weak and fatigued even as the scale drops. The effect intensifies in older adults, where muscle loss accelerates naturally with age.
Experts emphasize that the muscle loss occurs without intentional effort from patients. The appetite-suppressing effects of these medications make it harder for people to consume enough protein to maintain their muscle mass. Combined with reduced physical activity during rapid weight loss, the body preferentially metabolizes muscle tissue.
The emerging treatment aims to preserve muscle during obesity medication use. By targeting the biological pathways responsible for muscle breakdown, the drug could allow patients to experience the metabolic benefits of weight loss while retaining the lean tissue critical for long-term health.
For now, resistance training and adequate protein intake remain the most accessible defenses against medication-induced muscle loss. Patients taking these obesity drugs should prioritize strength exercises and ensure they consume sufficient protein, even as appetite decreases. Healthcare providers should monitor patients for signs of excessive muscle wasting and discuss these preventive strategies from the start of treatment